<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39336500</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1648-9144</ISSN><JournalIssue CitedMedium="Internet"><Volume>60</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>06</Day></PubDate></JournalIssue><Title>Medicina (Kaunas, Lithuania)</Title><ISOAbbreviation>Medicina (Kaunas)</ISOAbbreviation></Journal><ArticleTitle>Changes in the Success and Characteristics of Tobacco Dependence Treatment before and during the COVID-19 Pandemic: Clinical Sample Comparisons.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1459</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/medicina60091459</ELocationID><Abstract><AbstractText><i>Background and Objectives</i>: There is little information on changes in the process and outcomes of intensive tobacco dependence treatment during the COVID-19 pandemic. The following characteristics were evaluated: interest in treatment, the number of face-to-face or telephone follow-ups, the duration of pharmacotherapy use, and the success rate. The aim of our study was to compare the number of patients who entered tobacco dependence treatment programmes and evaluate the one-year success rate in patients three years before and three years after the COVID-19 pandemic. <i>Materials and Methods</i>: A single-site retrospective cohort study using data from patients treated at the Centre for Tobacco Dependence in Prague, Czech Republic, between 2017 and 2022 (n = 2039) was performed. The one-year abstinence rate was validated by measuring carbon monoxide in exhaled air (6 ppm cut-off). Patients were divided into two groups: the group for which treatment was initiated in 2017-2019 (i.e., before the COVID-19 pandemic, BC; n= 1221) and the group for which treatment was initiated in 2020-2022 (i.e., during the COVID-19 pandemic, DC; n = 818). <i>Results</i>: No significant differences in the success rate of tobacco dependence treatment were found between the two groups (BC group, 40.5% (494/1221) vs. DC group, 42.2% (345/818)) (<i>χ</i><sup>2</sup> (1, <i>N</i> = 2.039) = 0.6, <i>p</i> = 0.440). Furthermore, differences were not found in sex, education level, age at first cigarette, the duration of pharmacotherapy use, or the number of in-person visits. In contrast, there was an increase in the number of telephone contacts between the groups (18.7% (SD = 17.5%) vs. 32.9% (SD = 18.2%), <i>p</i> &lt; 0.001). <i>Conclusions</i>: The number of patients who started treatment during the COVID-19 pandemic decreased by one-third compared to that during the 3-year period before the pandemic. The overall treatment success rate did not change significantly even with the increase in the number of telephone visits with the therapist.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Stepankova</LastName><ForeName>Lenka</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zvolska</LastName><ForeName>Kamila</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pankova</LastName><ForeName>Alexandra</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rafl</LastName><ForeName>Jakub</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-5102-9354</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Donin</LastName><ForeName>Gleb</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-3786-5932</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tichopad</LastName><ForeName>Ales</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1308-0877</Identifier><AffiliationInfo><Affiliation>Department of Biomedical Technology, Faculty of Biomedical Engineering, Czech Technical University in Prague, 27201 Kladno, Czech Republic.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kralikova</LastName><ForeName>Eva</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Tobacco Dependent of the 3rd Medical Department, Department of Endocrinology and Metabolism, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Hygiene and Epidemiology, First Faculty of Medicine, Charles University in Prague and General University Hospital, 12808 Prague, Czech Republic.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>207037-1, and 207031-6</GrantID><Agency>Chrales University Cooperatio Program, research area Metabolic Diseases 207037-1, and research area Health Sciences: Public Health, Hygiene and Epidemiology, Occupational Medicine</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D003160">Comparative Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Medicina (Kaunas)</MedlineTA><NlmUniqueID>9425208</NlmUniqueID><ISSNLinking>1010-660X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014029" MajorTopicYN="Y">Tobacco Use Disorder</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018153" MajorTopicYN="N" Type="Geographic">Czech Republic</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016540" MajorTopicYN="N">Smoking Cessation</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19 pandemic</Keyword><Keyword MajorTopicYN="N">tobacco dependence</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>29</Day><Hour>1</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39336500</ArticleId><ArticleId IdType="pmc">PMC11434142</ArticleId><ArticleId IdType="doi">10.3390/medicina60091459</ArticleId><ArticleId IdType="pii">medicina60091459</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating Tobacco Use and Dependence: 2008 Update U.S. Public Health Service Clinical Practice Guideline Executive Summary. Respir. Care. 2008;53:1217–1222.</Citation><ArticleIdList><ArticleId IdType="pubmed">18807274</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofori S., Lu C., Olasupo O.O., Dennis B.B., Fairbairn N., Devereaux P.J., Mbuagbaw L. Cytisine for Smoking Cessation: A Systematic Review and Meta-Analysis. Drug Alcohol Depend. 2023;251:110936. doi: 10.1016/j.drugalcdep.2023.110936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drugalcdep.2023.110936</ArticleId><ArticleId IdType="pubmed">37678096</ArticleId></ArticleIdList></Reference><Reference><Citation>Králíková E., Češka R., Pánková A., Štěpánková L., Zvolská K., Felbrová V., Kulovaná S., Zvolský M. Doporučení pro Léčbu Závislosti Na Tabáku. Vnitř. Lékařství. 2015;61((Suppl. 1)):3–15.</Citation><ArticleIdList><ArticleId IdType="pubmed">26955915</ArticleId></ArticleIdList></Reference><Reference><Citation>Policy Recommendations for Smoking Cessation and Treatment of Tobacco Dependence: Tools for Public Health.  [(accessed on 17 May 2024)].  Available online:  https://www.who.int/publications-detail-redirect/policy-recommendations-for-smoking-cessation-and-treatment-of-tobacco-dependence-tools-for-public-health.</Citation></Reference><Reference><Citation>Bommele J., Hopman P., Walters B.H., Geboers C., Croes E., Fong G.T., Quah A.C.K., Willemsen M. The Double-Edged Relationship between COVID-19 Stress and Smoking: Implications for Smoking Cessation. Tob. Induc. Dis. 2020;18:63. doi: 10.18332/tid/125580.</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tid/125580</ArticleId><ArticleId IdType="pmc">PMC7386200</ArticleId><ArticleId IdType="pubmed">32733178</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Renzo L., Gualtieri P., Pivari F., Soldati L., Attinà A., Cinelli G., Leggeri C., Caparello G., Barrea L., Scerbo F., et al. Eating Habits and Lifestyle Changes during COVID-19 Lockdown: An Italian Survey. J. Transl. Med. 2020;18:229. doi: 10.1186/s12967-020-02399-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02399-5</ArticleId><ArticleId IdType="pmc">PMC7278251</ArticleId><ArticleId IdType="pubmed">32513197</ArticleId></ArticleIdList></Reference><Reference><Citation>Klemperer E.M., West J.C., Peasley-Miklus C., Villanti A.C. Change in Tobacco and Electronic Cigarette Use and Motivation to Quit in Response to COVID-19. Nicotine Tob. Res. 2020;22:1662–1663. doi: 10.1093/ntr/ntaa072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntaa072</ArticleId><ArticleId IdType="pmc">PMC7197523</ArticleId><ArticleId IdType="pubmed">32343816</ArticleId></ArticleIdList></Reference><Reference><Citation>Koopmann A., Georgiadou E., Reinhard I., Müller A., Lemenager T., Kiefer F., Hillemacher T. The Effects of the Lockdown during the COVID-19 Pandemic on Alcohol and Tobacco Consumption Behavior in Germany. Eur. Addict. Res. 2021;27:242–256. doi: 10.1159/000515438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000515438</ArticleId><ArticleId IdType="pmc">PMC8247814</ArticleId><ArticleId IdType="pubmed">33902030</ArticleId></ArticleIdList></Reference><Reference><Citation>Sidor A., Rzymski P. Dietary Choices and Habits during COVID-19 Lockdown: Experience from Poland. Nutrients. 2020;12:1657. doi: 10.3390/nu12061657.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12061657</ArticleId><ArticleId IdType="pmc">PMC7352682</ArticleId><ArticleId IdType="pubmed">32503173</ArticleId></ArticleIdList></Reference><Reference><Citation>Rantis K., Panagiotidis P., Parlapani E., Holeva V., Tsapakis E., Diakogiannis I. Substance Use during the COVID-19 Pandemic in Greece. J. Subst. Use. 2021;27:231–238. doi: 10.1080/14659891.2021.1941344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14659891.2021.1941344</ArticleId></ArticleIdList></Reference><Reference><Citation>Mellos E., Paparrigopoulos T. Substance Use during the COVID-19 Pandemic: What Is Really Happening? Psychiatr. Psychiatr. 2022;33:17–20. doi: 10.22365/jpsych.2022.072.</Citation><ArticleIdList><ArticleId IdType="doi">10.22365/jpsych.2022.072</ArticleId><ArticleId IdType="pubmed">35255473</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D.T. The psychosocial impact of the COVID-19 pandemic on changes in smoking behavior: Evidence from a nationwide survey in the UK. Tob. Prev. Cessat. 2020;6:59. doi: 10.18332/tpc/126976.</Citation><ArticleIdList><ArticleId IdType="doi">10.18332/tpc/126976</ArticleId><ArticleId IdType="pmc">PMC7643580</ArticleId><ArticleId IdType="pubmed">33163705</ArticleId></ArticleIdList></Reference><Reference><Citation>Csémy L., Dvořáková Z., Fialová A., Kodl M., Malý M., Skývová M. Národní Výzkum Užívání Tabáku a Alkoholu v České Republice 2021 (NAUTA). Státní Zdravotní Ústav, Praha. 2022.  [(accessed on 15 August 2024)].  Available online:  https://archiv.szu.cz/uploads/documents/szu/aktual/NAUTA_2021.pdf.</Citation></Reference><Reference><Citation>Samuels E.A., Clark S.A., Wunsch C., Jordison Keeler L.A., Reddy N., Vanjani R., Wightman R.S. Innovation during COVID-19: Improving Addiction Treatment Access. J. Addict. Med. 2020;14:e8–e9. doi: 10.1097/ADM.0000000000000685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/ADM.0000000000000685</ArticleId><ArticleId IdType="pmc">PMC7236851</ArticleId><ArticleId IdType="pubmed">32404652</ArticleId></ArticleIdList></Reference><Reference><Citation>Ornell F., Moura H.F., Scherer J.N., Pechansky F., Kessler F.H.P., von Diemen L. The COVID-19 Pandemic and Its Impact on Substance Use: Implications for Prevention and Treatment. Psychiatry Res. 2020;289:113096. doi: 10.1016/j.psychres.2020.113096.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2020.113096</ArticleId><ArticleId IdType="pmc">PMC7219362</ArticleId><ArticleId IdType="pubmed">32405115</ArticleId></ArticleIdList></Reference><Reference><Citation>Harker N., Johnson K., Erasmus J., Myers B. COVID 19-Impact on Substance Use Treatment Utilization and Provision in South Africa. Subst. Abuse Treat. Prev. Policy. 2022;17:15. doi: 10.1186/s13011-022-00446-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13011-022-00446-6</ArticleId><ArticleId IdType="pmc">PMC8892117</ArticleId><ArticleId IdType="pubmed">35241095</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.E., Garnett C., Shahab L., Oldham M., Brown J. Association of the COVID-19 Lockdown with Smoking, Drinking and Attempts to Quit in England: An Analysis of 2019–20 Data. Addiction. 2021;116:1233–1244. doi: 10.1111/add.15295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15295</ArticleId><ArticleId IdType="pmc">PMC8436745</ArticleId><ArticleId IdType="pubmed">33089562</ArticleId></ArticleIdList></Reference><Reference><Citation>Meacham M.C., Vogel E.A., Thrul J., Ramo D.E., Satre D.D. Addressing Cigarette Smoking Cessation Treatment Challenges during the COVID-19 Pandemic with Social Media. J. Subst. Abuse Treat. 2021;129:108379. doi: 10.1016/j.jsat.2021.108379.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsat.2021.108379</ArticleId><ArticleId IdType="pmc">PMC7982643</ArticleId><ArticleId IdType="pubmed">34080550</ArticleId></ArticleIdList></Reference><Reference><Citation>Jorge A., Rodriguez M.D., Joseph R., Betancourt M.D., Thomas D., Sequist M.D., Ishani Ganguli M.D. Differences in the Use of Telephone and Video Telemedicine Visits during the COVID-19 Pandemic. Am. J. Manag. Care. 2021;27:21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10877492</ArticleId><ArticleId IdType="pubmed">33471458</ArticleId></ArticleIdList></Reference><Reference><Citation>Baum A., Kaboli P.J., Schwartz M.D. Reduced In-Person and Increased Telehealth Outpatient Visits during the COVID-19 Pandemic. Ann. Intern. Med. 2021;174:129–131. doi: 10.7326/M20-3026.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3026</ArticleId><ArticleId IdType="pmc">PMC7429994</ArticleId><ArticleId IdType="pubmed">32776780</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark T.L., Treiman K., Padwa H., Henretty K., Tzeng J., Gilbert M. Addiction Treatment and Telehealth: Review of Efficacy and Provider Insights during the COVID-19 Pandemic. Psychiatr. Serv. 2022;73:484–491. doi: 10.1176/appi.ps.202100088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.ps.202100088</ArticleId><ArticleId IdType="pubmed">34644125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.E., Cox S., Shahab L., Brown J. Prevalence of Use and Real-World Effectiveness of Smoking Cessation Aids during the COVID-19 Pandemic: A Representative Study of Smokers in England. Addiction. 2022;117:2504–2514. doi: 10.1111/add.15903.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15903</ArticleId><ArticleId IdType="pmc">PMC9347508</ArticleId><ArticleId IdType="pubmed">35491743</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayhan Tetik B., Gedik Tekinemre I., Taş S. The Effect of the COVID-19 Pandemic on Smoking Cessation Success. J. Community Health. 2021;46:471–475. doi: 10.1007/s10900-020-00880-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10900-020-00880-2</ArticleId><ArticleId IdType="pmc">PMC7340767</ArticleId><ArticleId IdType="pubmed">32643078</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhuizen S., Selby P., Wong B., Zawertailo L. Effect of COVID-19 on Smoking Cessation Outcomes in a Large Primary Care Treatment Programme: An Observational Study. BMJ Open. 2021;11:e053075. doi: 10.1136/bmjopen-2021-053075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-053075</ArticleId><ArticleId IdType="pmc">PMC8392738</ArticleId><ArticleId IdType="pubmed">34446503</ArticleId></ArticleIdList></Reference><Reference><Citation>Turan P.A., Turan O. Impacts of the Covid-19 Pandemic on Smoking Cessation Success. Afr. Health Sci. 2023;23:431–436. doi: 10.4314/ahs.v23i3.50.</Citation><ArticleIdList><ArticleId IdType="doi">10.4314/ahs.v23i3.50</ArticleId><ArticleId IdType="pmc">PMC10862625</ArticleId><ArticleId IdType="pubmed">38357112</ArticleId></ArticleIdList></Reference><Reference><Citation>Blithikioti C., Nuño L., Paniello B., Gual A., Miquel L. Impact of COVID-19 Lockdown on Individuals under Treatment for Substance Use Disorders: Risk Factors for Adverse Mental Health Outcomes. J. Psychiatr. Res. 2021;139:47–53. doi: 10.1016/j.jpsychires.2021.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychires.2021.05.006</ArticleId><ArticleId IdType="pmc">PMC8769683</ArticleId><ArticleId IdType="pubmed">34029833</ArticleId></ArticleIdList></Reference><Reference><Citation>West R., Hajek P., Stead L., Stapleton J. Outcome Criteria in Smoking Cessation Trials: Proposal for a Common Standard. Addiction. 2005;100:299–303. doi: 10.1111/j.1360-0443.2004.00995.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1360-0443.2004.00995.x</ArticleId><ArticleId IdType="pubmed">15733243</ArticleId></ArticleIdList></Reference><Reference><Citation>Králíková E., Zvolská K., Štěpánková L., Pánková A. Tobacco Dependence Treatment Guidelines. Cas. Lek. Cesk. 2022;161:33–43.</Citation><ArticleIdList><ArticleId IdType="pubmed">35354292</ArticleId></ArticleIdList></Reference><Reference><Citation>Nides M., Rigotti N.A., Benowitz N., Clarke A., Jacobs C. A Multicenter, Double-Blind, Randomized, Placebo-Controlled Phase 2b Trial of Cytisinicline in Adult Smokers (The ORCA-1 Trial) Nicotine Tob. Res. 2021;23:1656–1663. doi: 10.1093/ntr/ntab073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntab073</ArticleId><ArticleId IdType="pmc">PMC8403245</ArticleId><ArticleId IdType="pubmed">33847362</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepankova L., Kralikova E., Zvolska K., Pankova A., Adamcekova Z., Kuhn M., Noland D. Comparison between Success Rates for Smokers Re-Treated by a Smokers’ Clinic and Success Rates for Smokers Treated for the First Time. Addiction. 2021;116:346–355. doi: 10.1111/add.15175.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/add.15175</ArticleId><ArticleId IdType="pubmed">32592219</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajkova D., Sandora J., Žídková R., Malinakova K., Novak L. Effects of the COVID-19 pandemic on Czech citizens: How do depression and anxiety symptoms influence cognitive, behavioral, and emotional changes? Front. Psychol. 2023;14:1204824. doi: 10.3389/fpsyg.2023.1204824.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2023.1204824</ArticleId><ArticleId IdType="pmc">PMC10331469</ArticleId><ArticleId IdType="pubmed">37434884</ArticleId></ArticleIdList></Reference><Reference><Citation>Bäuerle A., Teufel M., Musche V., Weismüller B., Kohler H., Hetkamp M., Dörrie N., Schweda A., Skoda E.M. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: A cross-sectional study in Germany. J. Public Health. 2020;42:672–678. doi: 10.1093/pubmed/fdaa106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/pubmed/fdaa106</ArticleId><ArticleId IdType="pmc">PMC7454766</ArticleId><ArticleId IdType="pubmed">32657323</ArticleId></ArticleIdList></Reference><Reference><Citation>Mamun M.A., Sakib N., Gozal D., Bhuiyan A.I., Hossain S., Bodrud-Doza M., Al Mamun F., Hosen I., Safiq M.B., Abdullah A.H., et al. The COVID-19 pandemic and serious psychological consequences in Bangladesh: A population-based nationwide study. J. Affect. Disord. 2021;279:462–472. doi: 10.1016/j.jad.2020.10.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2020.10.036</ArticleId><ArticleId IdType="pmc">PMC7568472</ArticleId><ArticleId IdType="pubmed">33120247</ArticleId></ArticleIdList></Reference><Reference><Citation>Midorikawa H., Aiba M., Lebowitz A., Taguchi T., Shiratori Y., Ogawa T., Takahashi A., Takahashi S., Nemoto K., Arai T., et al. Confirming validity of the Fear of COVID-19 Scale in Japanese with a nationwide large-scale sample. PLoS ONE. 2021;16:e0246840. doi: 10.1371/journal.pone.0246840.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0246840</ArticleId><ArticleId IdType="pmc">PMC7875410</ArticleId><ArticleId IdType="pubmed">33566868</ArticleId></ArticleIdList></Reference><Reference><Citation>Remr J. Psychometric Performance of the Fear of COVID-19 Scale (FCV-19S) and Its Validation in Czechia. Sustainability. 2023;15:8990. doi: 10.3390/su15118990.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/su15118990</ArticleId></ArticleIdList></Reference><Reference><Citation>Stănculescu E. Fear of COVID-19 in Romania: Validation of the Romanian Version of the Fear of COVID-19 Scale Using Graded Response Model Analysis. Int. J. Ment. Health Addict. 2022;20:1094–1109. doi: 10.1007/s11469-020-00428-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11469-020-00428-4</ArticleId><ArticleId IdType="pmc">PMC7787708</ArticleId><ArticleId IdType="pubmed">33432266</ArticleId></ArticleIdList></Reference><Reference><Citation>Broche-Pérez Y., Fernández-Fleites Z., Jiménez-Puig E., Fernández-Castillo E., Rodríguez-Martin B.C. Gender and Fear of COVID-19 in a Cuban Population Sample. Int. J. Ment. Health Addict. 2022;20:83–91. doi: 10.1007/s11469-020-00343-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11469-020-00343-8</ArticleId><ArticleId IdType="pmc">PMC7292241</ArticleId><ArticleId IdType="pubmed">32837428</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomura A., Tanigawa T., Muto T., Oga T., Fukushima Y., Kiyosue A., Miyazaki M., Hida E., Satake K. Clinical Efficacy of Telemedicine Compared to Face-to-Face Clinic Visits for Smoking Cessation: Multicenter Open-Label Randomized Controlled Noninferiority Trial. J. Med. Internet Res. 2019;21:e13520. doi: 10.2196/13520.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/13520</ArticleId><ArticleId IdType="pmc">PMC6660118</ArticleId><ArticleId IdType="pubmed">30982776</ArticleId></ArticleIdList></Reference><Reference><Citation>Richter K.P., Shireman T.I., Ellerbeck E.F., Cupertino A.P., Catley D., Cox L.S., Preacher K.J., Spaulding R., Mussulman L.M., Nazir N., et al. Comparative and Cost Effectiveness of Telemedicine versus Telephone Counseling for Smoking Cessation. J. Med. Internet Res. 2015;17:e113. doi: 10.2196/jmir.3975.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/jmir.3975</ArticleId><ArticleId IdType="pmc">PMC4468596</ArticleId><ArticleId IdType="pubmed">25956257</ArticleId></ArticleIdList></Reference><Reference><Citation>Minian N., Veldhuizen S., Tanzini E., Duench S., deRuiter W.K., Barker M., Zawertailo L., Melamed O.C., Selby P. Changes in the Reach of a Smoking Cessation Program in Ontario, Canada, during the COVID-19 Pandemic: A Cross-Sectional Study. CMAJ Open. 2021;9:E957–E965. doi: 10.9778/cmajo.20210053.</Citation><ArticleIdList><ArticleId IdType="doi">10.9778/cmajo.20210053</ArticleId><ArticleId IdType="pmc">PMC8526090</ArticleId><ArticleId IdType="pubmed">34667076</ArticleId></ArticleIdList></Reference><Reference><Citation>Veldhuizen S., Mahinpey N., Zawertailo L., Minian N., Melamed O., Selby P. Effects of COVID-19-Related Disruptions on Service Use in a Large Smoking Cessation Program. Nicotine Tob. Res. 2022;24:1567–1572. doi: 10.1093/ntr/ntac103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ntr/ntac103</ArticleId><ArticleId IdType="pmc">PMC9047198</ArticleId><ArticleId IdType="pubmed">35420694</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandi P., Asare S., Majmundar A., Xue Z., Han X., Westmaas J.L., Nargis N., Jemal A. Changes in Smoking Cessation-Related Behaviors among US Adults during the COVID-19 Pandemic. JAMA Netw. Open. 2022;5:e2225149. doi: 10.1001/jamanetworkopen.2022.25149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.25149</ArticleId><ArticleId IdType="pmc">PMC9344362</ArticleId><ArticleId IdType="pubmed">35913738</ArticleId></ArticleIdList></Reference><Reference><Citation>Melamed O.C., deRuiter W.K., Buckley L., Selby P. Coronavirus Disease 2019 and the Impact on Substance Use Disorder Treatments. Psychiatr. Clin. N. Am. 2022;45:95–107. doi: 10.1016/j.psc.2021.11.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2021.11.006</ArticleId><ArticleId IdType="pmc">PMC8585604</ArticleId><ArticleId IdType="pubmed">35219445</ArticleId></ArticleIdList></Reference><Reference><Citation>Zvolská K., Zvolský M., Čady J., Králíková E. Intenzivní léčba závislosti na tabáku v Česku v letech 2010–2022. Časopis Lékařů Českých. 2024;163:44–48.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>